+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-11-16Number of Pages: 80

Autoimmune Disease Diagnostics Market: (By Test Types: Antinuclear Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-Reactive Protein Test, Erythrocyte Sedimentation Rate, Urinalysis and Others; Disease: Graves’ Disease, Hashimoto’s Thyroiditis, Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, Type 1 Diabetes, and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Autoimmune diseases are characterized by inflammatory reactions caused by the hyperactive immune response of the body due to damage to own cells and body tissues. There are more than 80 types of autoimmune diseases prevalent in men and women. According to the National Institute of Health (NIH), autoimmune diseases are among the top ten causes of death in women in the U.S. Autoimmune disease diagnostics include the diagnostics procedures and tests that assist in identification of disease type and stage. Symptoms associated with autoimmune diseases include fatigue, inflammation, fever, rashes, and joint pain. The increasing prevalence of autoimmune diseases, rising public awareness and supportive government policies are the major factors driving the global autoimmune disease diagnostics market. According to the American Autoimmune Related Diseases Association (AARDA), currently, 50 million people in the U.S. are living with autoimmune diseases. In addition, advancement in diagnostic procedures, improved laboratory techniques and growing healthcare expenditure across the world are also expected to propel the market of autoimmune disease diagnostics. For instance, government organizations across the world are increasing their spending to provide better health care services. For instance, an analysis based on preliminary government data by the Centers for Medicare & Medicaid Services revealed that health care spending in the U.S. increased by 5% in 2014 as compared to 3.6% in 2013.

The global autoimmune disease diagnostics market has been estimated on the basis of test types and diseases. The market for autoimmune disease diagnostics is divided into eight segments on the basis of tests: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. Autoantibody tests accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market due to high sensitivity and specificity. Moreover, the main advantages of antibody-based tests are their speed, simplicity, and minimal patient discomfort. 
On the basis of disease the autoimmune disease diagnostics market is categorized into seven segments: Graves’ disease, Hashimotos’s thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. Rheumatoid arthritis accounted for the largest market share in 2014 in terms of revenue and continues to dominate the market due to the rising prevalence of rheumatoid arthritis across the world and improved laboratory tests for the diagnosis of rheumatoid arthritis

Geographically, autoimmune disease diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World. North America held the largest share of 39.0% of the global autoimmune disease diagnostics market in terms of revenue in 2014 followed by Europe. Rising patient population, presence of major players and well-structured distribution channel are driving the growth of these regions. Asia Pacific was the third largest market for autoimmune disease diagnostics, and is expected to register the fastest CAGR during the forecast period. Large untapped opportunities, improving health care infrastructure, increasing prevalence of autoimmune diseases, and expansion of market players  in the region would contribute to the market growth.

Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux, Siemens Healthcare, Inova Diagnostics, Inc., Quest Diagnostics, and SQL Diagnostics, Inc. are some of the major players operating in the global autoimmune disease diagnostics market. Most of these players are constantly striving to retain or enhance their market share by developing technologically advanced products.

autoimmune-disease-diagnostics-market

 


1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Autoimmune Disease Diagnostics: Market Snapshot
     2.2. Global Autoimmune Disease Diagnostics Market, by Test Type, 2014 (US$ Mn)
     2.3. Global Autoimmune Disease Diagnostics Market Share, by Geography, 2014–2023 (US$ Mn)

3. Global Autoimmune Disease Diagnostics Market – Industry Analysis
     3.1. Introduction
     3.2. Drivers
           3.2.1. High Prevalence of Autoimmune Diseases Across the World
           3.2.2. Increased Health Care Expenditure Globally
           3.2.3. Growing Awareness Among People About Autoimmune Diseases
     3.3. Restraints
           3.3.1. Competitive Pricing and Equipment Costs
           3.3.2. Shortage of Skilled Labor
     3.4. Opportunities
           3.4.1. Emerging Economies to Offer Sustained Growth Opportunities
           3.4.2. New products, Services, and Device Development
     3.5. Porter’s Five Forces Analysis 
     3.6. Market Attractiveness Analysis– Autoimmune Disease Diagnostics Market, by Geography, 2014 (%) 
     3.7. Competitive Landscape – Autoimmune Disease Diagnostics Market, by Key Players, 2014 (%)

4.  Market Segmentation – By Test Type
     4.1. Introduction
     4.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     4.3. Global Antinuclear Antibody Test Market Revenue, 2013–2023 (US$ Mn)
     4.4. Global Autoantibody Test Market Revenue, 2013–2023 (US$ Mn)
     4.5. Global Complete Blood Count Market Revenue, 2013–2023 (US$ Mn)
     4.6. Global Comprehensive Metabolic Panel Market Revenue, 2013–2023 (US$ Mn)
     4.7. Global C-reactive Protein Market Revenue, 2013–2023 (US$ Mn)
     4.8. Global Erythrocyte Sedimentation Rate Market Revenue, 2013–2023 (US$ Mn)
     4.9. Global Urinalysis Market Revenue, 2013–2023 (US$ Mn)
     4.10. Global Other Tests Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation – By Disease Type
     5.1. Introduction
     5.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     5.3. Global Graves’ Disease Market Revenue, 2013–2023 (US$ Mn)
     5.4. Global Hashimoto’s Thyroiditis Market Revenue, 2013–2023 (US$ Mn)
     5.5. Global Multiple Sclerosis Market Revenue, 2013–2023 (US$ Mn)
     5.6. Global Rheumatoid Arthritis Market Revenue, 2013–2023 (US$ Mn)
     5.7. Global Systemic Lupus Erythematosus Market Revenue, 2013–2023 (US$ Mn)
     5.8. Global Type 1 Diabetes Market Revenue, 2013–2023 (US$ Mn)
     5.9. Global Other Diseases Market Revenue, 2013–2023 (US$ Mn)

6. Autoimmune Disease Diagnostics Market - Regional Analysis
     6.1. Introduction
     6.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.3. North America Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.4. Europe Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.5. Asia Pacific Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
     6.6. RoW Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)

7. Recommendations

8. Company Profiles
     8.1. Abbott Laboratories, Inc.
     8.2. Beckman Coulter, Inc. 
     8.3. bioMérieux SA 
     8.4. Bio-Rad Laboratories 
     8.5. F.Hoffmann-La Roche Ltd.
     8.6. Inova Diagnostics, Inc.
     8.7. Quest Diagnostics 
     8.8. SQI Diagnostics, Inc. 
     8.9. Siemens Healthcare

This report on the autoimmune disease diagnostics market studies the current and future prospects of the global market. Autoimmune disease diagnostics market includes various laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. The rising prevalence of autoimmune diseases, increase in health care expenditure globally, rising government initiatives and increasing automation in laboratories leading to higher sensitivity, faster and easy performance will drive the market of autoimmune disease diagnostics. The autoimmune disease diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global autoimmune disease diagnostics market with respect to market segments based on the test type and diseases and their geographic analysis.

Based on test type, the autoimmune disease diagnostics market has been segmented into eight major categories: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. On the basis of disease the autoimmune disease diagnostics market is categorized into seven segments namely: Graves’ disease, Hashimotos’s thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, autoimmune disease diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global autoimmune disease diagnostics market.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the autoimmune disease diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux SA, Siemens Healthcare, Inova Diagnostics Inc., Quest Diagnostics and SQL Diagnostics, Inc.

The global autoimmune disease diagnostics market is segmented as follows:

Global Autoimmune Disease Diagnostics Market, by Test Type

  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C - reactive protein (CRP)
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

 

Global Autoimmune Disease Diagnostics Market, by Disease Type

  • Graves' Disease
  • Hashimoto's Thyroiditis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus (lupus)
  • Type 1 diabetes
  • Others

Global Autoimmune Disease Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa